Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:32
  • Read more about Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:30
  • Read more about Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach

Genetics of smoking and risk of clonal hematopoiesis

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:29
  • Read more about Genetics of smoking and risk of clonal hematopoiesis

Shared genetic loci between depression and cardiometabolic traits

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:27
  • Read more about Shared genetic loci between depression and cardiometabolic traits

Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:25
  • Read more about Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease

Genome-wide association analysis and replication in 810,625 individuals with varicose veins

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:23
  • Read more about Genome-wide association analysis and replication in 810,625 individuals with varicose veins

GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:19
  • Read more about GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:14
  • Read more about Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study

A meta-analysis of genome-wide association studies in 614,243 individuals identifies 59 novel susceptibility loci underlying Dupuytren’s contracture

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:11
  • Read more about A meta-analysis of genome-wide association studies in 614,243 individuals identifies 59 novel susceptibility loci underlying Dupuytren’s contracture

Cancer risk in individuals with autism spectrum disorder

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:07
  • Read more about Cancer risk in individuals with autism spectrum disorder

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 387
  • Page 388
  • Page 389
  • Page 390
  • Current page 391
  • Page 392
  • Page 393
  • Page 394
  • Page 395
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement